We are happy to announce that our society has successfully engaged in the initiative to change the name of Polycystic Ovary Syndrome (PCOS). Polyendocrine Metabolic Ovarian Syndrome (PMOS) is now the new name for the condition, which impacts 1 in 8, or more than 170 million women worldwide.
The AE- PCOS society leadership was part of the Name Change Steering Committee, and many of its members were involved in the rigorous process of selecting the new name.
AE-PCOS Society Dedicated to improving Women's Health.
The Androgen Excess and Polycystic Ovary Syndrome Society is an international organization dedicated to promoting the generation and dissemination of knowledge related to all aspects of Androgen Excess Disorders.
To promote knowledge, and original clinical and basic research, in every aspect of androgen excess disorders in order to improve the understanding, diagnosis, treatment, and prevention of these disorders.
The Society will strive to serve as the premier international multidisciplinary organization fostering and encouraging quality and innovation in clinical and basic research related to the etiology, diagnosis, treatment, and prevention of androgen excess disorders.
The Androgen Excess & PCOS Society Board of Directors manages the affairs of the Society. The Board consists of the President, President Elect, Vice President, Executive Director, immediate Past-Presidents, Secretary/Treasurer, and four Directors-at-Large.
Join a network of premier experts in Androgen Excess Disorders
